Home › Funds › Logos Global Management LP › COGT
Logos Global Management LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Logos Global Management LP reported holding 1,250,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$40.0M, representing 2.41% of its reported portfolio and ranking #15 among its reported holdings. Logos Global Management LP has disclosed COGT holdings in 4 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's COGT position evolved
Logos Global Management LP first disclosed a stake in COGT in Q3 2024 at 2,000,000 shares (US$21.6M). The position peaked in Q3 2026 at 1,250,000 shares, worth US$40.0M. Across 4 filings, Logos Global Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,250,000 shares valued at US$40.0M — an increase of 350,000 shares quarter over quarter.. Notable position changes include a 39% increase in Q3 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.00M | $21.60M | New |
| Q3 2025 | 500.00K | $7.18M | New |
| Q2 2026 | 900.00K | $34.83M | New |
| Q3 2026 | 1.25M | $40.02M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 48 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held COGT?
Logos Global Management LP has disclosed COGT holdings in 4 of the last 9 reported quarters, going back to Q3 2024.
What is Logos Global Management LP's current position in COGT?
As of Q3 2026, Logos Global Management LP holds 1.25M shares of COGT (COGENT BIOSCIENCES INC), valued at $40.02M, representing 2.41% of its reported portfolio and ranking #15.
Has Logos Global Management LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Logos Global Management LP increased its position in COGT. The position peaked in Q3 2026 at 1.25M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Kynam Capital Management, LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.